KUALA LUMPUR, Malaysia, Oct. 1, 2025 -- The Minister of Health, Y.B. Datuk Seri Dr. Dzulkefly Ahmad today announced that the selection and evaluation process of finding MHTC new Chief Executive Officer (CEO) is officially concluded with the appointment of Encik Suriaghandi Suppiah effective 29 September 2025. Suriaghandi's career is marked by his ability to lead transformation initiatives, strengthen operations, and drive sustainable growth across diverse sectors. Most recently, he has served as Healthcare Advisor to the Employees Provident Fund (EPF), where he played a pivotal
MELBOURNE, Australia, Sept. 30, 2025 -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces its record-breaking conference presence with 28 company-related abstract presentations at the 38th Annual Congress of the European Association of Nuclear Medicine (EANM) to be held in Barcelona from 4 – 8 October 2025. Dr. David N. Cade, Telix Group Chief Medical Officer, said, "We are pleased to showcase our late-stage and next generation development programs and innovations in MedTech at EANM – the largest gathering of nuclear med
KUALA LUMPUR, Malaysia, Sept. 30, 2025 -- Emagene Life, Asia's leader in functional medicine and longevity, is proud to announce its official international partnership with the Institute for Functional Medicine (IFM), the leading voice for functional medicine for more than 30 years. This landmark collaboration aligns Emagene Life with the confident and competent practice of functional medicine worldwide, combining clinical excellence, education, and partnerships across medical disciplines. Leading the Future of Functional Medicine and Longevity Emagene Life is the first
SHANNAN, China, Oct. 1, 2025 -- Angel Yeast (SH600298), a global leader in yeast and biotechnology, today announced that its subsidiary Xizang Angel Zhufeng Biotechnology Co., Ltd. ("Angel Zhufeng"), located on the Qing-Zang Plateau, has officially commenced operations at the world's first high-altitude probiotic production facility. The state-of-the-art plant has completed its first shipment of the Bifidobacterium lactis XZ-BI36 probiotic powder. "Every stage of production is carried out in oxygen-free conditions—setting a new industry benchmark for qual
TOKYO, Oct. 1, 2025 -- Taiwan Cell Manufacturing Company (tcmc), a state-of-the-art CDMO specializing in cell and gene therapy (CGT) manufacturing, is participating in BioJapan 2025 - Asia's premier biotechnology exhibition – taking place October 8-10 in Yokohama, Japan. At this influential event, tcmc will showcase its world-class CDMO services, foster strategic collaborations, and champion innovation in CAR-T cell therapy and regenerative medicine across Asia and beyond. tcmc is Taiwan's PIC/S GMP-compliant facility dedicated to the commercial manufacturing of genetically mod
European leader in space infrastructure, payload integration and mission operations joins Starlab to strengthen international reach and extend capabilities for Starlab customers HOUSTON and SYDNEY, Oct. 1, 2025 -- Starlab Space LLC at the 76th International Astronautical Congress today announced that Space Applications Services, a Belgium-based leader in space engineering and payload integration, has joined the company as a joint venture partner and investor. The partnership expands Starlab's global footprint and extends the capabilities available to Starlab customers. &
ADELAIDE, Australia, Oct. 1, 2025 -- Fleet Space Technologies, Australia's leading space exploration company, has officially opened its new global headquarters (GHQ) and space-tech hyperfactory at Adelaide Airport's Catalyst Park. Fleet Space's 5,300m²+ facility boosts Australia's advanced manufacturing capacity, enabling the production of thousands of next-generation geophysical sensors and hundreds of satellites annually. By vertically integrating its business operations - supply chain, design, manufacturing, operations, engineering and R&D within a state-of-the-art facilit
[ 메디채널 김갑성 기자 ] 상하이 2025년 9월 30일 -- 이노맥스 메디컬 테크놀로지(InnoMax Medical Technology Co., Ltd., 이하 '이노맥스 메드테크')가 9월 24일부터 26일까지 사흘간 열린 '2025 메드텍 차이나(2025 Medtec China)'에서 휴대용 메쉬 분무기, 휴대용 산소 농축기, AI 기반 수면 보조 장치, 주사 펜, 혈당 측정기 등 의료 영상 및 호흡기 치료 분야를 아우르는 다양한 제품을 선보였다. 모두 독자 개발한 제품들로, 의료 및 의료기술 전문가들의 큰 관심을 끌었다. 잭슨 시(Jackson Shih) 이노맥스 메드테크 회장은 25일 생방송 인터뷰에서 "당사의 제품 포트폴리오는 체외 진단과 의료 영상부터 호흡기 치료와 스마트 재활 및 웨어러블 건강 기기에 이르기까지 다양한 핵심 의료 분야를 아우른다"면서 "이노맥스 메드테크는 중국 기반 CDMO(계약 개발 및 제조 기관)로서 전 세계 고객에게 의료 기기에 대한 엔드투엔드(end-to-end) 정밀 개발•제조 서비스를 제공한다"고 말했다. 시 회장은 이어 "단일
- Clinical study conducted at the Dementia Research Centre, Nanyang Technological University, Singapore, involving Southeast Asian participants - Expert level accuracy, while significantly reducing analysis time for white matter hyperintensity and gray matter volume SEOUL, South Korea, Sept. 30, 2025 -- Neurophet (Co-CEOs Jake Junkil Been and Donghyeon Kim), an artificial intelligence (AI) solution company for brain disorders diagnosis and treatment, announced on the 30th that the results of a clinical study validating the clinical efficacy of its brain neurodegeneration
Both companies are intensifying their collaboration and combining technological expertise to strengthen German aircraft development through digital engineering and emission-reducing innovations. WESSLING, Germany, Sept. 30, 2025 -- Akkodis and Deutsche Aircraft have signed a cooperation agreement, marking the beginning of a strategic partnership. The goal is to significantly advance the development and production of innovative regional aircraft in Germany – with a focus on technological excellence and strengthening the local aerospace ecosystem.